Abstract
Ca 2+ currents resistant to organic Ca 2+ channel antagonists are present in different types of central neurons. Here, we describe the properties of such currents in CA1 neurons acutely dissociated from rat hippocampus. Blocker-resistant Ca 2+ currents were isolated by combined application of N-, P/Q- and L-type Ca 2+ current antagonists (ω-conotoxin GVIA 2 μM; ω-conotoxin MVIIC 3 μM; ω-agatoxin IVA 200 nM; nifedipine 10 μM) and constituted approximately 21% of the total Ba 2+ current. The blocker-resistant current showed properties similar to R-type currents in other cell types, i.e. voltages of half-maximal inactivation and activation of −76 and −17 mV, respectively, and strong inactivation during the test pulse. In addition, blocker-resistant Ca 2+ currents in CA1 neurons displayed a characteristically rapid deactivation. Application of mock action potentials revealed that charge transfer through blocker-resistant Ca 2+ channels is highly sensitive to action potential shape and changes in resting membrane voltage. Pharmacological experiments showed that these currents were highly sensitive to the divalent cation Ni 2+ (half-maximal block at 28 μM), but were relatively resistant to the spider toxin SNX-482 (8% and 52% block at 0.1 and 1 μM, respectively). In addition to the functional analysis, we examined the expression of pore-forming and accessory Ca 2+ channel subunits on the messenger RNA level in isolated CA1 neurons using quantitative real-time polymerase chain reaction. Of the pore-forming α subunits encoding high-threshold Ca 2+ channels, Ca v2.1, Ca v2.2 and Ca v2.3 messenger RNA levels were most prominent, corresponding to the high proportion of N-, P/Q- and R-type currents in these neurons. In summary, CA1 neurons display blocker-resistant Ca 2+ currents with distinctive biophysical and pharmacological properties similar to R-type currents in other neuron types, and express Ca 2+ channel messenger RNAs that give rise to R-type Ca 2+ currents in expression systems.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
